A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.
暂无分享,去创建一个
Klaus Rasmussen | K. Rasmussen | L. Thuesen | T. Nielsen | T. Haghfelt | P. Grande | S. Husted | F. Pedersen | H. Kelbaek | H. Andersen | L. Krusell | Per Thayssen | Torben Haghfelt | Henning Kelbaek | A. Villadsen | J. Madsen | Ulrik Abildgaard | Leif Thuesen | P. Thayssen | Leif Spange Mortensen | L. S. Mortensen | Peer Grande | Henning R Andersen | Torsten T Nielsen | Flemming Pedersen | Jan K Madsen | Anton B Villadsen | Lars R Krusell | Preben Lomholt | Steen E Husted | Else Vigholt | Henrik K Kjaergard | Else Vigholt | U. Abildgaard | H. Kjaergård | P. Lomholt
[1] J. Reiber,et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. , 1993, The New England journal of medicine.
[2] H. Arendrup,et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. , 1997, Circulation.
[3] M. Simoons,et al. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. , 1997, The New England journal of medicine.
[4] P. Touboul,et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study , 2002, The Lancet.
[6] J O'Keefe,et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .
[7] R. Zahn,et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. , 2000, The New England journal of medicine.
[8] J. Rumsfeld,et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. , 2000, JAMA.
[9] K. Bailey,et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. , 1993, The New England journal of medicine.
[10] William W O'Neill,et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. , 2002, Journal of the American College of Cardiology.
[11] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[12] M. Morice,et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. , 2001, The New England journal of medicine.
[13] J. Boura,et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .
[14] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[15] J. J. Griffin,et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.
[16] T. Nielsen,et al. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). , 2003, American heart journal.
[17] M. Aschermann,et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2. , 2003, European heart journal.
[18] W. Rogers,et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. , 2000, The New England journal of medicine.
[19] K. Fox,et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial , 2002, The Lancet.
[20] E. Antman,et al. Is recurrent myocardial infarction following thrombolytic administration associated with long-term mortality? , 2002 .